ResearcherKeio UniversityNo recent work listed
Hiromasa Takaishi
Matched on OpenAlex author ID A5043802284. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper
Papers 5
- Post-progression survival following second-line chemotherapy in patients with advanced pancreatic cancer previously treated with gemcitabine: a meta-analysis. Last author DOI 10.1007/s10637-018-0589-6↗
- Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postprogression survival for first-line chemo… Co-author DOI 10.1007/s00280-017-3263-3↗
- Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer. Co-author DOI 10.1111/cas.12621↗
- Mesenchymal stem cells regulate epithelial-mesenchymal transition and tumor progression of pancreatic cancer cells. Co-author DOI 10.1111/cas.12059↗
- Chemoresistance is associated with cancer stem cell-like properties and epithelial-to-mesenchymal transition in pancreatic cancer cells. Co-author PMID 22993328↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yasuo Hamamoto · 5 shared papers, 2012–2018 · strength 0.24
- Paper Post-progression survival following second-line chemotherapy in patients with advanced pancreatic cancer previously tre… DOI 10.1007/s10637-018-0589-6↗
- Paper Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postp… DOI 10.1007/s00280-017-3263-3↗
- Paper Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancre… DOI 10.1111/cas.12621↗
- Takanori Kanai∥ · 2 shared papers, 2017–2018 · strength 0.14
- Paper Post-progression survival following second-line chemotherapy in patients with advanced pancreatic cancer previously tre… DOI 10.1007/s10637-018-0589-6↗
- Paper Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postp… DOI 10.1007/s00280-017-3263-3↗
- Akiyoshi Kasuga · 2 shared papers, 2017–2018 · strength 0.14
- Paper Post-progression survival following second-line chemotherapy in patients with advanced pancreatic cancer previously tre… DOI 10.1007/s10637-018-0589-6↗
- Paper Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postp… DOI 10.1007/s00280-017-3263-3↗
- Naohiro Okano · 1 shared paper, 2018 · strength 0.07
- Koichi Aiura · 2 shared papers, 2013–2015 · strength 0.07
- Yuko Kitagawa · 2 shared papers, 2013–2015 · strength 0.07
- Toshifumi Hibi∥ · 2 shared papers, 2012–2013 · strength 0.06
- Makoto Sunamura · 1 shared paper, 2015 · strength 0.04
- Masato Okamoto · 1 shared paper, 2015 · strength 0.04
- Shuhei Mayanagi · 1 shared paper, 2015 · strength 0.04
- Hiroya Takeuchi · 1 shared paper, 2015 · strength 0.04
- Minoru Kitago · 1 shared paper, 2015 · strength 0.04
- Ayano Kabashima‐Niibe · 1 shared paper, 2013 · strength 0.03
- Shigeyuki Kawachi · 1 shared paper, 2013 · strength 0.03
- Yohei Masugi · 1 shared paper, 2013 · strength 0.03
- Michiie Sakamoto · 1 shared paper, 2013 · strength 0.03
- Motoko Izumiya · 1 shared paper, 2012 · strength 0.03
- Ayano Kabashima · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.